The results displayed that PCa patients with ITGA1/ITGA2 copy number loss/del were associated with shorter biochemical recurrence‐free survival in three distinct PCa cohorts (Figure S1i–n, Supporting Information). The gene discussed is ITGA1; the disease is posterior cortical atrophy.